Primary C-fiber nociceptors are broadly divided into peptidergic and nonpeptidergic afferents. TRPV1 is a thermosensitive cation channel mainly localized in peptidergic nociceptors, whereas MrgD is a sensory G protein-coupled receptor expressed in most nonpeptidergic nociceptive afferents. TRPV1
Introduction
Primary sensory neurons consist of heterogeneous cell populations that reside in sensory ganglia. Their terminals in peripheral tissues transduce noxious and innocuous stimuli of different modalities-mechanical, thermal, and chemical. The diversity of these neurons has been defined at the functional, electrophysiological, and molecular levels. Their neurochemical characterization revealed a number of genetic markers used to classify them and associate them with specific functions.
Heat transduction in C-fiber nociceptors has been mainly attributed to the TRPV1 channel, but its deletion in mice had partial effects on noxious heat sensitivity, indicating the presence of other noxious heat sensors. 3, 4, 8 Of interest, ablation of TRPV1 1 fibers produced a complete loss of thermal sensitivity in mice, arguing that this neuronal population is necessary for the detection of thermal stimuli. 6 In mice, TRPV1 is a marker of the peptidergic subset of sensory neurons characterized by the expression of neuroactive and vasoactive peptides, such as calcitonin generelated peptide (CGRP) and substance P. Anatomically, peptidergic afferents project to lamina I and the outer part of lamina II of the dorsal horn of the spinal cord. 1, 13, 20 On the other hand, most nonpeptidergic nociceptors express the purinergic receptor P2X3 and bind the isolectin IB4. The Mas-related G protein-coupled receptor subtype D (MrgD) has been identified as a marker of this subpopulation as its expression covers most P2X3 1 neurons. Nonpeptidergic primary afferents project centrally to the middle/ inner part of lamina II of the dorsal horn and terminate peripherally as free nerve endings mostly in the skin epidermis and dermis. 13, 20, 21, 25 Ablation of MrgD 1 neurons significantly reduced mechanical sensitivity with mice displaying higher von Frey thresholds under normal and inflammatory conditions. 6 Selective modulation of these neuronal subsets is valuable in dissecting their differential contribution to nociception and chronic pain. Although useful, ablation strategies have the caveat of potential compensatory mechanisms in somatosensory circuits. Here, we describe optogenetic approaches to achieve precise and selective activation of 2 major genetically identified and nonoverlapping subpopulations of adult nociceptors.
Optogenetics consists of the heterologous expression of photosensitive actuators, such as channelrhodopsin-2 (ChR2), to modulate cellular activity with high spatiotemporal resolution. 18, 19 By targeting ChR2-Venus to the MrgD locus, Wang and Zylka selectively activated MrgD 1 fibers and assessed their connectivity to second-order neurons in the dorsal horn of spinal cord. However, they did not report any behavioral results, presumably due to low opsin levels insufficient to drive light-induced responses. 24 To overcome this limitation and avoid any nonspecific opsin expression due to developmental regulation of MrgD, 15 we used an inducible, Cre-dependent strategy to deliver ChR2 to mature MrgD 1 nociceptors. However, knowing that TRPV1 expression is also developmentally modulated 5 and due to the lack of an inducible TRPV1-Cre transgenic line, we used the constitutive TRPV1-Cre mouse line coupled to a viral delivery approach to induce the selective expression of ChR2 in TRPV1
1 dorsal root ganglia (DRG) neurons in adult mice. We report here the functional phenotyping of the TRPV1-ChR2 and MrgD-ChR2 mouse lines based on histological, electrophysiological, and behavioral analysis.
Methods

Transgenic mouse lines
Six-to 16-week-old TRPV1-ChR2 or MrgD-ChR2 mice of both sexes, weighing 20 to 35 g, were used in this study. Animals were kept on a 12:12-hour light/dark cycle, with food and water provided ad libitum. All animal procedures were performed in accordance with the McGill University Animal Care Committee regulations.
Homozygous TRPV1-Cre mice (The Jackson Laboratory) were injected intrathecally with an adeno-associated virus (AAV) 2/8 virus (AAV2/8-CAG-floxed stop-ChR2[H134R]-tdTomato-WPRE) at the age of 6 weeks to generate TRPV1-ChR2 mice. This approach allowed us to deliver the opsins after the developmental regulation of TRPV1 has occurred. 5 Intrathecal injections were performed free hand in nonanesthetized mice as described previously. 10, 11 Briefly, a 30 g half-inch needle connected to a length of PE10 tubing and attached to a 50 mL Luer-hub Hamilton syringe was inserted into the L5-L6 intervertebral space (at the level of the cauda equina), and virus (5 mL; titer .5 3 10 12 gc/mL) was injected over a 2-second period. Appropriate placement of the needle was confirmed by observing a brief twitch of the tail. Experiments were conducted 4 to 6 weeks after injection because ChR2 expression decreased after this time (confirmed by decreased light-induced pain behaviors).
Homozygous MrgD CreERT2 mice (kindly provided by Dr. Wenqin Luo, University of Pennsylvania) were crossed with homozygous Ai32 mice (The Jackson Laboratory). MrgD CreERT2 mice carry the CreERT2 construct in the MrgD coding exons, allowing its expression under the control of the MrgD promoter. Ai32 mice carry in the ROSA26 locus the floxed stop-ChR2(H134R)-EYFP construct. 17 These crossings generated the MrgD-ChR2 transgenic mouse line. All experimental animals were heterozygous for both MrgD and the ROSA26 transgenes. To induce opsin expression in MrgD-ChR2 mice, tamoxifen (100 mL, 10 mg/mL) was injected intraperitoneally for 5 consecutive days starting at P14, alternating between the sides of injection. To control for tamoxifen injections, the same procedure was performed on heterozygous MrgD CreERT2 mice.
Immunofluorescence
Mice were intracardially perfused with 50 mL saline, followed by 50 mL of ice-cold 4% paraformaldehyde in 0.1 M phosphate buffer, pH 7.4. DRG, spinal cord, and glabrous skin were extracted and postfixed in 4% paraformaldehyde for 1 hour at room temperature. Tissue was then cryoprotected in 30% sucrose in 0.01 M phosphate-buffered saline (PBS) overnight at 4˚C. To study the spinal cord, 30 mm-thick sections were cut at 2 20˚C using a cryostat (Leica) collected as free floating in PBS containing 0.2% Triton-X (PBS-T). As for the DRG and skin, sectioning at 14mm-thickness was performed directly onto gelatin-subbed slides. 
Cell culture and dorsal root ganglion preparation
Dorsal root ganglia were extracted from adult TRPV1-ChR2 or MrgD-ChR2 mice and kept in sterile ice-cold 1x Hanks Balanced Salt Solution medium (Invitrogen) throughout the dissection. Dorsal root ganglia were then incubated in 5 mL of Hanks Balanced Salt Solution containing 1.4 mg/mL dispase (SigmaAldrich) and 1.1 mg/mL collagenase type II (Sigma-Aldrich) for 45 minutes at 37˚C. After the enzymatic reaction, DRG were washed once with F-12 culture media (Invitrogen), containing 10% fetal bovine serum, 1% L-glutamine, 1% penicillin, and 1% streptomycin, and then mechanically triturated using fire-polished Pasteur pipettes. The dissociated neurons were finally plated onto 35-mm culture dishes (Sarstedt, 2 mL/dish) previously coated with laminin (BD Bioscience, Mississauga, Ontario, Canada) and poly-D-lysine (Sigma-Aldrich). Cells were incubated for 2 hours at 37˚C and 5% CO 2 before electrophysiological recording. Because a significant downregulation of capsaicin responses was observed in TRPV1-ChR2 neurons 24 to 72 hours after plating (data not shown), electrophysiological recordings were conducted using acutely dissociated DRG neurons.
Electrophysiology
Whole-cell patch-clamp recordings on DRG neurons were conducted at room temperature, 2 to 6 hours after plating. The pipette's internal solution (pH 7.2) contained the following in mM: 130 K-gluconate, 1 MgCl 2 , 10 HEPES, 5 EGTA, 3 MgATP, and 0.4 GTP. The bath solution, pH 7.4, contained the following in mM: 152 NaCl, 5 KCl, 2 CaCl 2 , 1 MgCl 2 , 10 HEPES, and 10 glucose. Patch pipettes had a tip resistance of 5 to 10 MV. Electrophysiological recordings were conducted using an Axopatch 200B amplifier, digitized with a Digidata 1322A interface (Axon Instruments, Sunnyvale, CA). Traces were acquired and analyzed using pClamp 8.2 software (Axon Instruments). Recordings were low-pass filtered at 2 and 5 KHz in voltage and current clamp configurations, respectively. Multimode optic fibers (200 mm diameter; Thorlabs), coupled to diodepumped solid-state lasers of specific wavelengths (473 nm blue laser, Laserglow Technologies; or 589 nm yellow laser, Dragon Lasers), were used for optical stimulation of DRG neurons. Stimulation parameters are specified in each condition. Light intensities were measured using a PM100A power meter coupled to a S130C photodiode sensor (Thorlabs) and analyzed using LabVIEW 8.5.
Acute light-induced nocifensive behaviors
Mice were habituated for 1 hour in transparent Plexiglas cubicles set atop a half-inch glass floor and separated from each other by opaque dividers. Acute nocifensive behaviors were elicited using a pulsing laser (473 nm blue light, at 2, 5, and 10 Hz) set at different intensities and aimed at the plantar surface of the hind paws. For each condition, three 20-second trials were conducted, alternating between the left and right hind paws with at least 3 minutes between trials. Scored nocifensive behaviors included purposeful hind paw withdrawal, hind paw licking, and hind paw lifting. Hind paw withdrawal consisted of paw removal to avoid the optical stimulus followed immediately by replacing the paw on the glass floor. Hind paw lifting consisted of removing the paw and keeping it lifted for a prolonged period. The percentage of trials in which these behaviors occurred is reported. The number of paw withdrawals and the time spent lifting or licking per trial were also quantified in the trials where such behaviors occurred. In control animals not expressing ChR2, optical stimulation (2, 5, and 10 Hz) did not produce any behavior, even when the highest light intensity was applied for 20 seconds (see Supplementary Materials for video; available online at http://links.lww.com/PAIN/A455, http://links.lww.com/PAIN/ A456, and http://links.lww.com/PAIN/A457).
Light-induced conditioned place aversion assay
A shuttle box, composed of 2 equal-sized compartments with distinct visual cues (one has horizontal black stripes and the other has vertical black stripes), placed over a glass surface was used for a consecutive 5-day experimental procedure. On day 1, during habituation sessions 1 and 2, mice freely explored the 2 compartments for 10 minutes. On sessions 3 to 8, in the control condition, each mouse received yellow light illumination (2 Hz, 8 mW/mm 2 for 10 minutes) on the right hind paw, and was confined to the nonpain-paired compartment during illumination; in the experimental condition, the left hind paw was stimulated with blue light (2 Hz, 8 mW/mm 2 for 10 minutes), and was confined to the pain-paired compartment. On day 5 (test session), each mouse was allowed to freely explore the 2 compartments for 5 minutes, and the time spent in each compartment was recorded. The percent time spent in each compartment was calculated by dividing the time spent in that particular compartment by the time spent in both compartments multiplied by 100. Conditioning sessions were balanced so half the mice had the horizontal black stripe compartment as the pain-paired compartment, whereas the other half had the vertical black stripe compartment associated with the painful stimulus. Sessions were also balanced so half of the mice received blue light first, whereas the other half received yellow light first.
Data analysis
Data analysis was performed in Excel, graphs plotted in SigmaPlot 11, and statistics (Student t test or 2-way analysis of variance) analyzed in Prism GraphPad 6. Data are expressed as the mean 6 SEM; P values are indicated in the figure legends.
Results
Cellular distribution of ChR2 in TRPV1
1 or MrgD
To investigate the expression profile of ChR2 opsins in the peripheral pathways of TRPV1-ChR2 mice, we visualized the endogenous ChR2-tdTomato fluorescence directly and immunostained for the nonpeptidergic marker P2X3, normally absent in TRPV1 1 afferents. In the dorsal horn of the spinal cord, bright tdTomato fluorescence was detected exclusively in lamina I and outer lamina II, dorsal to the green signal of nonpeptidergic P2X3 1 fibers, in a region well known to be innervated by peptidergic primary afferents (Fig. 1A) . 5 In the periphery, tdTomato 1 free nerve endings were rather sparse and did not overlap with P2X3
1 fibers (Fig. 1B) . The small number of tdTomato 1 fibers seen in the skin most probably reflects the relatively low number of DRG neurons transduced by the intrathecal delivery of ChR2-tdTomato (Fig. 1C) . Indeed, only 15.6% 6 1.6% of CGRP 1 DRG neurons expressed tdTomato. All (100%) TdTomato 1 cells were small diameter sensory neurons expressing CGRP, whereas a small proportion of them were found to be positive for P2X3 (4.1% 6 2.0%, 4 out of 88 neurons) (Fig. 1C) . Our data confirm the selective expression of ChR2-tdTomato in TRPV1
1
/CGRP
1 nociceptive neurons and its efficient trafficking to the most distal ends of the primary afferents.
Conversely, to assess the exclusive expression of ChR2 channels in nonpeptidergic sensory neurons of MrgD-ChR2 mice, we performed immunostaining for the peptidergic marker CGRP, expecting virtually no overlap with the cellular distribution of ChR2-EYFP. Direct EYFP fluorescence signal was strong in DRG, spinal cord, and glabrous skin, indicating that tamoxifen administration efficiently induced ChR2-EYFP expression and that opsins are well trafficked to both central and peripheral terminals. In the dorsal horn of the spinal cord, the EYFP signal was detected in the inner part of lamina II (lamina IIi), ventral to the area of termination of CGRP afferents, demonstrating the selective expression of ChR2-EYFP in nonpeptidergic nociceptive neurons ( Fig. 2A) . In the periphery, EYFP 1 fibers terminated as free nerve endings often extending more superficially in the epidermis than CGRP 1 fibers (Fig. 2B) . All (100%) EYFP 1 DRG neurons were positive for the nonpeptidergic marker IB4, whereas 76.4% 6 4.3% of IB4 1 neurons were EYFP 1 , demonstrating that this inducible transgenic approach achieved a high coverage of the nonpeptidergic C-fiber subset. Only 0.92% 6 0.68% (3 of 310) of EYFP 1 neurons expressed CGRP (Fig. 2C) photocurrents in neurons from both TRPV1-ChR2 and MrgDChR2 mice (peak current density of 27.83 6 3.27 and 14.08 6 1.67 pA/pF for TRPV1-ChR2 and MrgD-ChR2, respectively), exhibiting typical ChR2 current phenotype and kinetics. Furthermore, short blue light pulses delivered at 1 Hz frequency were sufficient to reliably evoke action potentials in either tdTomato 1 or EYFP 1 neurons (Fig. 3A, B) , suggesting that transdermal optical stimulation may efficiently activate these specific subsets of primary afferents in vivo. Crucially, every photosensitive TRPV1-ChR2 DRG neuron displayed an inward TRPV1-mediated current evoked by capsaicin application 4 (100%, 11/11 neurons; Fig. 3A,   C) . Similarly, all blue light-sensitive DRG neurons from MrgDChR2 mice responded to the selective P2X3 agonist a,b-meATP with typical homomeric P2X3 currents 9 (100%, 8/8 neurons; Fig.  3B, C) . Unexpectedly, our recordings showed that within the TRPV1 1 population responding to both blue light and capsaicin, some cells also responded to a,b-meATP (6/11 neurons) (Fig.  3B, C) . Conversely, 3 of 8 MrgD 1 neurons responded to capsaicin in addition to a,b-meATP and blue light (Fig. 3C) . However, different P2X current profiles were recorded in the 2 subsets of nociceptors: MrgD-ChR2 DRG neurons consistently displayed homomeric P2X3 channels, whereas TRPV1-ChR2 neurons mainly expressed heteromeric P2X213 channels (Fig.  3C) . Nevertheless, our patch-clamp data confirm that all ChR2 1 neurons from TRPV1-ChR2 mice express TRPV1, whereas all ChR2 1 neurons from MrgD-ChR2 mice express P2X3.
Acute light-induced behavioral responses in TRPV1-ChR2 and MrgD-ChR2 mice
To assess whether selective activation of TRPV1 1 or MrgD 1 fibers induces behavioral responses in freely moving mice, we transdermally stimulated the glabrous skin of the hind paws of TRPV1-ChR2 or MrgD-ChR2 mice with blue light (473 nm) using a range of increasing intensities (2.19-7.93 mW/mm 2 ) and increasing pulsing frequencies (2, 5, and 10 Hz). In TRPV1-ChR2 mice, the main behaviors detected under optical stimulation were paw withdrawal (Fig. 4A, B) , paw lifting (Fig. 4C) , and paw licking (Fig. 4D) , whereas paw lifting occurred less frequently even at high laser intensities (Fig. 4C) . Although not significant, the light-induced nocifensive behaviors tended to be intensity dependent, except for light-evoked lifting (Fig. 4C) .
In MrgD-ChR2 mice, the predominant behaviors under optical illumination consisted of paw withdrawal (Fig. 5A, B) and paw (Fig. 5C ). Paw licking also occurred, although to a lesser extent (Fig. 5D) . The profile of these nocifensive behaviors was not significantly different across the various optical parameters tested, indicating that nocifensive responses were saturated at the lowest light intensity and that these behaviors are frequency independent. The behavioral profile of MrgD-ChR2 mice in response to blue light was globally milder than that of Na v 1.8-ChR2 1 mice that exhibited robust paw withdrawal, paw licking, jumping, and audible vocalization in response to similar stimulation parameters. 7 Altogether, our data confirm the expression of ChR2 in the glabrous skin of both TRPV1-ChR2 and MrgD-ChR2 mice and indicate that the level of expression is sufficiently high to generate nocifensive behaviors in freely moving mice. Our data also show that peripheral activation of peptidergic TRPV1 1 or nonpeptidergic MrgD 1 C-fiber primary afferents in the glabrous skin drives distinct behavioral responses.
The most striking difference in light-induced behaviors between TRPV1-ChR2 and MrgD-ChR2 mice was the total time they spent licking or lifting the illuminated paw, respectively (see Supplementary Materials for video recordings of representative light-induced behavioral responses in these 2 ChR2-expressing mouse lines and in a control mouse line; available online at http:// links.lww.com/PAIN/A455, http://links.lww.com/PAIN/A456, and http://links.lww.com/PAIN/A457). Indeed, TRPV1-ChR2 mice spent significantly more time licking the stimulated paw than MrgD-ChR2 mice at 2, 5, and 10 Hz pulsing frequencies (Fig. 6A) . Conversely, MrgD-ChR2 mice never licked for a prolonged time when blue light was applied to the hind paw. This was also the case at maximum light intensity. Of interest, the time spent licking the paw in TRPV1-ChR2 mice was intensity dependent (Fig. 6A) . However, MrgD-ChR2 mice spent significantly more time lifting their paws at 2, 5, and 10 Hz than TRPV1-ChR2 mice (Fig. 6B) . Quantitative analysis of the light-evoked responses of TRPV1-ChR2 and MrgD-ChR2 mice led us to propose that these behaviors reflect qualitatively different somatosensory perceptions.
Light-induced aversion in
To investigate the association of acute light-induced behaviors with the activation of supraspinal regions, we used the conditioned place aversion paradigm to assess the aversive motivational effects of activating TRPV1 1 or MrgD 1 primary afferents (Fig. 7A) . In the absence of optical stimulation or under yellow light stimulation (negative control), mice showed no preference to a particular compartment (Fig. 7B, C) . However, blue light was clearly aversive to TRPV1-ChR2 mice. Indeed, TRPV1-ChR2 mice spent significantly less time in the blue light-paired (painful) compartment compared with the yellow light-paired compartment (Fig. 7D) . Of interest, no place avoidance was observed in MrgD-ChR2 mice using the same conditioning parameters (Fig. 7D) , revealing different degrees of aversion between TRPV1
1 and MrgD 1 C-fiber activation, with potentially a nonaversive/nonpainful somatosensory perception after MrgD 1 fiber activation. Altogether, these results indicate a differential central processing of specific peripheral nociceptive inputs driving distinctive associative and motivational behaviors in mice.
Discussion
In this study, we present novel optogenetic mouse lines to specifically investigate functional differences in 2 major subsets of C-fiber nociceptors. Altogether, our results demonstrate the potential of these novel tools to investigate the physiological role of peptidergic and nonpeptidergic subpopulations of small diameter nociceptors in vivo. Taking advantage of the TRPV1-Cre and MrgD
CreERT2 driver lines, we selectively delivered optogenetic actuators to TRPV1
1 peptidergic and MrgD 1 nonpeptidergic neurons that together form the majority of nociceptors with minimal overlap. 6 In MrgD-ChR2 mice, the Cre-dependent expression of excitatory ChR2 channels was driven by the CAG promoter, overcoming the limitation of low opsin levels. 24 Moreover, the inducible Cre ERT2 construct allowed us to circumvent developmental regulation of the MrgD gene. To restrict opsin expression to the adult DRG population in TRPV1-ChR2 mice, 5 we intrathecally infected TRPV1-Cre adult mice with Cre-dependent AAVs. These approaches allowed for the first time the induction of light-induced pain behaviors by selectively activating peptidergic or nonpeptidergic subsets of primary afferents in freely moving mice.
Histological analysis validated the selective expression of ChR2 in MrgD 1 or TRPV1 1 neurons. In TRPV1-ChR2 mice, 100% of ChR2 1 cells were positive for the peptidergic marker, CGRP, and their central terminals were found mostly in lamina I and outer lamina II of the spinal cord, as expected. 5 Conversely, in MrgD-ChR2 mice, the almost exclusive expression of ChR2 in small diameter DRG neurons, its dorsal horn termination area restricted to lamina IIi, and its termination as free nerve endings in the superficial part of the skin, are all consistent with the previously described anatomical distribution of MrgD 1 afferents. 25 Moreover, the fact that 100% of ChR2 1 DRG neurons of MrgD-ChR2 mice expressed the marker IB4 confirms the selective targeting of nonpeptidergic C fibers. Our histological data confirm that both our transgenic strategies are effective to overcome developmental gene regulation that could lead to nonspecific expression in adult nociceptors. 6, 16 Our electrophysiological analysis showed that transgenic ChR2 opsins were efficient at driving firing activity, as photocurrents reliably induced action potentials in cultured DRG neurons from either MrgD-ChR2 or TRPV1-ChR2 mice. Moreover, 100% of ChR2 1 neurons from MrgD-ChR2 mice responded to a,b-meATP, and 100% of ChR2 1 from TRPV1-ChR2 mice responded to capsaicin, demonstrating that there is no leakage in the transgenic expression of ChR2 and that its expression is faithful to the targeted cell population. These results were correlated with our histological analysis showing that around 4% of TRPV1 1 neurons were positive for the nonpeptidergic marker, P2X3, and around 1% of MrgD 1 neurons were positive for the peptidergic marker CGRP. Of interest, in patch-clamp recordings, we observed that 55% of TRPV1
1 neurons responded to a,b-meATP, whereas 38% of MrgD 1 neurons were capsaicin sensitive, although with significantly smaller current densities than with their cognate agonist. A possible explanation for the discrepancy between our histological and electrophysiological data is that the process of isolation and dissociation of DRG neurons changes their gene expression, leading to a different profile than in vivo. Although an RNA sequencing study showed some overlap between mouse peptidergic and nonpeptidergic populations with a small fraction of neurons coexpressing TRPV1 and P2X3 mRNA [22] , our data confirm that ChR2 expression is restricted to 2 mutually exclusive populations of C-fiber nociceptors in vivo.
Based on the previous characterization of behavioral responses to acute transdermal illumination in Na v 1.8-ChR2
1 mice, 7 we evaluated the nocifensive behaviors generated by blue light stimulation of the plantar surface of the hind paws of TRPV1-ChR2 and MrgD-ChR2 mice. Acute illumination of the hind paw of TRPV1-ChR2 mice mainly generated prolonged licking behaviors, whereas activation of cutaneous MrgD 1 fibers mainly produced prolonged hind paw lifting responses. In both lines, these responses were milder than those observed previously in Na v 1.8-ChR2 1 mice. 7 Because the Na v 1.8 1 population is larger than the TRPV1 1 or MrgD 1 nociceptive populations, these results suggest that the intensity of the behavioral responses depends on the number of sensory afferents recruited by the optical stimulation. Furthermore, licking in MrgD-ChR2 mice was limited compared with TRPV1-ChR2 mice that display fast and prolonged paw licking in response to acute blue light, in agreement with the role of TRPV1 1 fibers in thermoreception and burning sensation. This difference in evoked stereotypical responses suggests that a behavioral output can be solely dictated by the subset of peripheral primary afferents activated. This provides evidence that basic sensory modalities can be coded early on in the pain pathways (labeled line) before they are differentially processed in the spinal cord and higher in the brain.
In addition to the phenotyping of acute behaviors on light stimulation, we assessed the role of TRPV1 1 and MrgD 1 fibers in more complex spontaneous behaviors. Using the conditioned place aversion paradigm, we showed that transdermal blue light stimulation of the paw in TRPV1-ChR2 mice represents a strong avoidance cue. Of interest, despite the acute behaviors observed under light stimulation in MrgDChR2 mice, no clear preference or avoidance was detected under these conditioning settings. One possible reason for this significant difference is that acute behaviors generated under optical stimulation are weaker in MrgD-ChR2 compared with TRPV1-ChR2 mice. One could argue that it is a matter of transgene penetrance, but our histological data show that the opsin is strongly expressed in most MrgD 1 C-fiber afferents in
MrgD-ChR2 mice. Moreover, the maximal optical activation of MrgD 1 fibers was reached because acute behaviors did not change with increasing light intensity. In mice, peptidergic fibers are known to be involved in thermosensation, whereas nonpeptidergic fibers transmit mechanical nociception. 6 As distinct acute optically induced behaviors were obvious between the 2 mouse lines, another possibility is that activation of MrgD 1 fibers, presumably mechanosensitive, triggers an aching, dull pain that is not sufficiently aversive to generate a place conditioning compared with activation of TRPV1 1 fibers that trigger a sharp, burning pain. Alternatively, the interpretation of the behaviors detected in MrgD-ChR2 mice as nocifensive may not be accurate. Mice may withdraw or lift their paws because of unpleasantness which may not be sufficient to drive aversion. Another explanation for the absence of avoidance behavior in MrgD-ChR2 mice may be that optical activation of a neuronal subset in isolation has not the same physiological impact as the synergistic activation of several types of mechanosensitive fibers evoked by natural stimuli. Our findings suggest that activation of the circuitry involving solely TRPV1
1 fibers has a more direct aversive effect. A study suggested a predominant role of nonpeptidergic nociceptors in the affective component of pain, 2 but this anatomical study was not corroborated with behavioral data. Genetically, the MrgD 1 and MrgB4 1 afferents, involved in the pleasant perception of stroking, 23 belong to the same Retdependent lineage of unmyelinated cutaneous nonpeptidergic C fibers. 12, 14, 22 It is therefore possible also that activation of MrgD 1 neurons is perceived as weakly aversive or even pleasant when appropriately tuned.
Altogether, we present new transgenic models in which specific subsets of C-fiber nociceptors are optogenetically controlled, leading to distinct nocifensive behaviors that translate into different aversion profiles in adult mice. This approach allowed for the first time the selective and temporally precise activation of TRPV1 1 or MrgD 1 fibers in nonanesthetized, freely moving mice and the characterization of the behavioral profile generated. This work not only provides new tools to tackle the physiological complexity of peripheral somatosensory pathways but also opens the door to the understanding of the contribution of various neuronal subsets to pain perception under chronic conditions.
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